CN1198941A - 'Kangruling' medicine mixture - Google Patents
'Kangruling' medicine mixture Download PDFInfo
- Publication number
- CN1198941A CN1198941A CN 98102359 CN98102359A CN1198941A CN 1198941 A CN1198941 A CN 1198941A CN 98102359 CN98102359 CN 98102359 CN 98102359 A CN98102359 A CN 98102359A CN 1198941 A CN1198941 A CN 1198941A
- Authority
- CN
- China
- Prior art keywords
- compatibility
- rhizoma
- type
- radix
- medicine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000003814 drug Substances 0.000 title claims abstract description 58
- 239000000203 mixture Substances 0.000 title claims description 17
- 208000002193 Pain Diseases 0.000 claims abstract description 17
- 210000000481 breast Anatomy 0.000 claims description 21
- 230000036541 health Effects 0.000 claims description 16
- 229940079593 drug Drugs 0.000 claims description 15
- 208000024891 symptom Diseases 0.000 claims description 14
- 241000195474 Sargassum Species 0.000 claims description 7
- 210000003734 kidney Anatomy 0.000 claims description 7
- 210000000582 semen Anatomy 0.000 claims description 6
- 241000283956 Manis Species 0.000 claims description 5
- 230000017531 blood circulation Effects 0.000 claims description 5
- 239000002775 capsule Substances 0.000 claims description 5
- 239000006187 pill Substances 0.000 claims description 5
- 239000008280 blood Substances 0.000 claims description 4
- 210000004369 blood Anatomy 0.000 claims description 4
- 230000001276 controlling effect Effects 0.000 claims description 4
- VYQNWZOUAUKGHI-UHFFFAOYSA-N monobenzone Chemical compound C1=CC(O)=CC=C1OCC1=CC=CC=C1 VYQNWZOUAUKGHI-UHFFFAOYSA-N 0.000 claims description 4
- 230000001105 regulatory effect Effects 0.000 claims description 4
- 239000003826 tablet Substances 0.000 claims description 4
- 230000002124 endocrine Effects 0.000 claims description 3
- 230000001737 promoting effect Effects 0.000 claims description 3
- 230000000694 effects Effects 0.000 abstract description 15
- 206010028980 Neoplasm Diseases 0.000 abstract 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 11
- 201000010099 disease Diseases 0.000 description 8
- 210000004185 liver Anatomy 0.000 description 5
- 206010006187 Breast cancer Diseases 0.000 description 4
- 208000026310 Breast neoplasm Diseases 0.000 description 4
- NKANXQFJJICGDU-QPLCGJKRSA-N Tamoxifen Chemical compound C=1C=CC=CC=1C(/CC)=C(C=1C=CC(OCCN(C)C)=CC=1)/C1=CC=CC=C1 NKANXQFJJICGDU-QPLCGJKRSA-N 0.000 description 4
- 201000008275 breast carcinoma Diseases 0.000 description 3
- 208000030270 breast disease Diseases 0.000 description 3
- 230000007812 deficiency Effects 0.000 description 3
- 208000035475 disorder Diseases 0.000 description 3
- 230000003054 hormonal effect Effects 0.000 description 3
- 239000005556 hormone Substances 0.000 description 3
- 229940088597 hormone Drugs 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 230000005906 menstruation Effects 0.000 description 3
- 230000008859 change Effects 0.000 description 2
- 230000007368 endocrine function Effects 0.000 description 2
- 239000012467 final product Substances 0.000 description 2
- 210000005075 mammary gland Anatomy 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 230000002265 prevention Effects 0.000 description 2
- 229960001603 tamoxifen Drugs 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 231100000331 toxic Toxicity 0.000 description 2
- 230000002588 toxic effect Effects 0.000 description 2
- DCXYFEDJOCDNAF-UHFFFAOYSA-N Asparagine Natural products OC(=O)C(N)CC(N)=O DCXYFEDJOCDNAF-UHFFFAOYSA-N 0.000 description 1
- 208000008035 Back Pain Diseases 0.000 description 1
- 206010008479 Chest Pain Diseases 0.000 description 1
- 206010062717 Increased upper airway secretion Diseases 0.000 description 1
- DCXYFEDJOCDNAF-REOHCLBHSA-N L-asparagine Chemical compound OC(=O)[C@@H](N)CC(N)=O DCXYFEDJOCDNAF-REOHCLBHSA-N 0.000 description 1
- 208000019255 Menstrual disease Diseases 0.000 description 1
- 206010034568 Peripheral coldness Diseases 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 239000003098 androgen Substances 0.000 description 1
- 229940027989 antiseptic and disinfectant iodine product Drugs 0.000 description 1
- 229960001230 asparagine Drugs 0.000 description 1
- 235000009582 asparagine Nutrition 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 210000000038 chest Anatomy 0.000 description 1
- 229940126678 chinese medicines Drugs 0.000 description 1
- 238000003748 differential diagnosis Methods 0.000 description 1
- 230000008034 disappearance Effects 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 238000002651 drug therapy Methods 0.000 description 1
- 229940011871 estrogen Drugs 0.000 description 1
- 239000000262 estrogen Substances 0.000 description 1
- 239000003172 expectorant agent Substances 0.000 description 1
- 230000003419 expectorant effect Effects 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 235000008216 herbs Nutrition 0.000 description 1
- 230000000938 luteal effect Effects 0.000 description 1
- 230000029849 luteinization Effects 0.000 description 1
- 206010025482 malaise Diseases 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000008506 pathogenesis Effects 0.000 description 1
- 208000026435 phlegm Diseases 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 230000002980 postoperative effect Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 239000000583 progesterone congener Substances 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 238000002636 symptomatic treatment Methods 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
A Chinese patent medicine including three prescriptions respectively for treating pain-type, pain plus tumor type and tumor-type mastoplasia features high curative effect and cure rate and convenient application.
Description
The present invention relates to the field of Chinese medicines, be particularly for a kind of Chinese patent medicine-'Kangruling ' medicine mixture for the treatment of cyclomastopathy.Be applicable to the cyclomastopathy of the various symptoms of treatment, the state of an illness, also can be as the prevention of breast carcinoma and the rehabilitation medication of breast carcinoma postoperative.
Cyclomastopathy is higher commonly encountered diseases, the frequently-occurring disease of popular a kind of sickness rate in the middle of the women, and normal not obvious because of therapeutic effect, the easy treatment that makes cyclomastopathy that shows effect repeatedly becomes the problem that medical circle is relatively paid close attention to.The Drug therapy of cyclomastopathy has two kinds of Chinese medicine and western medicine at present, and Chinese medicine has multiple, and have asparagine sheet, RUPIXIAO, breast commonly used increase Chinese patent medicines such as peaceful, and Western medicine is many with androgen or tamoxifen etc.Existing these Chinese patent medicine dispersing the stagnated live-QI to relieve the stagnation of QI, heat-clearing and toxic substances removing, the pain that disappears of invigorating blood circulation have certain curative effect to breast disease.But because these Chinese patent medicines mostly are to provide a drug matching, all be to use the fixedly good a kind of magistral medicines of compatibility promptly to cyclomastopathy dissimilar, symptom, therefore, in application, can not well realize symptomatic treatment, have deficiencies such as cure rate is low, easy recurrence.Amcinonides such as tamoxifen go out to send treatment from the hormonal balance of adjusting the patient, and certain curative effect is arranged, and bring toxic and side effects but take easily for a long time to the patient, and patient has the acceptance of being difficult for.
The objective of the invention is to disclose a kind of based on effect a permanent cure, the middle one-tenth new drug-'Kangruling ' medicine mixture for the treatment of both the principal and secondary aspects of a disease, the good effect of suiting the remedy to the case, treatment cyclomastopathy that cure rate is high.
Design of the present invention is the theoretical mechanism with the combination of Chinese and Western medicine, breast disease is carried out researching and analysing of etiology and pathogenesis, adopt the kidney invigorating to transfer and dash appoint, modulability hormonal balance and the traditional Chinese medical science distinguishes the method that the disease differential diagnosis of diseases combines, the new Chinese patent medicine of breast disease of a kind for the treatment of both the principal and secondary aspects of a disease of research preparation.
Task of the present invention is on the basis of insufficiency of kidney-YANG for this, realizes by the way to the different medicine of cyclomastopathy, the preparation of dissimilar, different symptoms, the different state of an illness.
Cyclomastopathy is to increase relevant with periodicity disorder of hormone secretion, mammary gland tissue to the sensitivity of hormone.Be relative or definitely too high, the long-time stimulus mammary gland tissue of estrogen luteal phase, and progestogen again hyposecretion lose due to the protective effect.Therefore, the present invention makes it should meet theory of Chinese medical science when medication, the kidney invigorating, soothing the liver, strongly fragrant, the softening the hard mass that looses, and treating both the principal and secondary aspects of a disease has the effect of the adjusting hormonal balance of Western medicine again, improves endocrine, thereby reaches better therapeutic effect, the unlikely again toxic and side effects of bringing.
" The liver and the kidney have a common source " insufficiency of kidney-YANG is this, is the theoretical foundation of medication of the present invention.Deficiency of kidney-QI, Chong and Ren channel disorder are for falling ill originally, and depression of liver-QI, the expectorant stasis of blood stagnate and be the mark of morbidity, deficiency of kidney-QI, the liver failing to be nourished, and the dredging of liver rushed down functional disorder, and stagnation of QI collection forms nodules of the breast with fixed attention.Therefore the present invention starts with from endocrine regulation, provided tonify Qi of the kidney, the Chinese medicine of the Chinese medicine of regulating thoroughfare and controlling vessel and dispersing the stagnated live-QI to relieve the stagnation of QI, hard masses softening and resolving, constituted basic compatibility of the present invention, to reach the purpose for the treatment of both the principal and secondary aspects of a disease.
Technical characterictic of the present invention is to change the way that existing Chinese patent medicine with a kind of compatibility is used for the cyclomastopathy of the different state of an illness, different symptoms, but according to the difference of morbidity process, the state of an illness, symptom, typing has been prepared the 'Kangruling ' medicine mixture of different compatibilities on the basis of basic compatibility.Concrete 'Kangruling ' medicine mixture is divided into I type, II type and three kinds of models of III type.Wherein the I type is a painful, and the II type is that pain adds the lump type, and the III type is the lump type, and being respectively applied for treatment pain is the master, the pain lump is concurrent and lump is the cyclomastopathy of three kinds of different symptoms of master.Basic compatibility of the present invention be by tonify Qi of the kidney, regulating thoroughfare and controlling vessel, dispersing the stagnated live-QI to relieve the stagnation of QI, the Herba Epimedii that improves endocrine function, Cornu Cervi Degelatinatum, Rhizoma Cyperi, Radix Bupleuri; The drug matchings such as Squama Manis, Semen Vaccariae, Medulla Tetrapanacis, Concha Ostreae that improve iodine products Sargassum, the Thallus Laminariae (Thallus Eckloniae) of luteal function, dissipating phlegm and resolving masses and the lactogenesis of invigorating blood circulation, hard masses softening and resolving, reducing swelling and alleviating pain constitute.The clever drug matching of health breast of three kinds of models is to have carried out the adjustment and the increase and decrease of medicine according to the difference of the state of an illness, symptom on the basis of basic compatibility, and typing has been mixed with the clever Chinese patent medicine of health breast of three kinds of different compatibilities.The clever Chinese patent medicine of health breast facilitates patients in order to make, absorption and instant effect, and the health breast spirit that the present invention provides is to make the oral liquid mixture with modern crafts to form.Also can make the Chinese patent medicine of other forms such as pill, capsule, tablet or decoction as required.
The present invention is owing to start with from balance hormone, adjustment endocrine function, at the different state of an illness and symptom, typing prepared based on tonify Qi of the kidney, the clever Chinese patent medicine of health breast of three kinds of models of regulating thoroughfare and controlling vessel, dispersing the stagnated live-QI to relieve the stagnation of QI, hard masses softening and resolving, make that medicine has that the property of suiting the medicine to the illness is strong, good effect, be difficult for advantage such as recurrence.
Specific embodiments of the invention are as follows:
Embodiment 1
Embodiment 1 has provided I type 'Kangruling ' medicine mixture
The spirit of I type health breast is the pain type, and being mainly used in what treat that stagnation of QI due to depression of the liver causes is the cyclomastopathy of cardinal symptom with pain, and its drug matching is as follows:
Herba Epimedii 10～20g, Cornu Cervi Degelatinatum 10～15g, Rhizoma Cyperi 10～15g, Radix Bupleuri 10～15g, Thallus Laminariae (Thallus Eckloniae) 15～20g, Sargassum 15～20g, Radix Rhapontici 10～15g, Semen Vaccariae 15～20g, Squama Manis 10～15g, Concha Ostreae 30g, Medulla Tetrapanacis 5～10g, Rhizoma Chuanxiong 10～15g, Radix Curcumae 10～15g, the Radix Paeoniae Alba 10～15g.
The Chinese patent medicine that the drink form that becomes to be convenient to absorb is refined in medicinal modern crafts preparation in the above-mentioned compatibility gets final product (Chinese patent medicine that also can be made into forms such as pill, capsule, tablet, decoction).
The spirit of I type health breast is on the basis of basic compatibility of the present invention, assistant matches with Radix Curcumae, the Radix Paeoniae Alba and Rhizoma Cyperi, Radix Bupleuri, constituted the drug matching of dispersing the stagnated live-QI to relieve the stagnation of QI, to symptom for, breast distension painful based on breast, lump be cannot find out or menstruation before pain increase the weight of, pain relief, lump dwindle disappearance, and with the cyclomastopathy of chest and back pain significant curative effect are arranged after the lump increase, menstruation.
Embodiment 2
Embodiment 2 has provided II type 'Kangruling ' medicine mixture
The spirit of II type health breast adds the lump type for pain, is mainly used in treatment pain and the simultaneous cyclomastopathy of lump.Its drug matching is as follows:
Herba Epimedii 15～20g, Cornu Cervi Degelatinatum 10～15g, Rhizoma Cyperi 5～10g, Radix Bupleuri 5～10g, Thallus Laminariae (Thallus Eckloniae) 15～20g, Sargassum 15～20g, Semen Vaccariae 15～20g, Concha Ostreae 30g, Medulla Tetrapanacis 5～10g.Radix Paeoniae Rubra 10～10g, Squama Manis 10～15g, rhizoma sparganic 15～20g, Rhizoma Curcumae 15～20g, Spina Gleditsiae 15～20g.
Above-mentioned drug matching is refined into oral liquid mixture form with the modern crafts preparation get final product (also can be made into forms such as pill, capsule, tablet or decoction).
The spirit of II type health breast is to adjust on the basis of basic compatibility of the present invention, and assistant forms with compatibility of drugss such as the Radix Paeoniae Rubra of blood circulation promoting and blood stasis dispelling, hard masses softening and resolving, rhizoma sparganic, Rhizoma Curcumae, Spina Gleditsiae.To symptom is that pain and lump exist simultaneously, with the cyclomastopathy of soreness of waist cold extremities, dizziness, menoxenia significant curative effect is arranged.
Embodiment 3
Embodiment 3 has provided III type 'Kangruling ' medicine mixture.
The spirit of III type health breast is the lump type, is mainly used in the cyclomastopathy of treatment based on lump, and its compatibility is as follows:
Radix Scrophulariae 10～20g, Herba Epimedii 10～20g, Cornu Cervi Degelatinatum 10～15g, Thallus Laminariae (Thallus Eckloniae) 10～20g, Sargassum 10～20g, Semen Vaccariae 10～20g, rhizoma sparganic 10～20g, Rhizoma Curcumae 10～15g, Spina Gleditsiae 10～20g, Bulbus Fritillariae Thunbergii 10～15g.
Refine into oral liquid mixture form with the modern crafts preparation, also can prepare the Chinese patent medicine of forms such as pill, tablet, decoction or capsule.
The spirit of III type health breast is to have adjusted the dispersing the stagnated live-QI to relieve the stagnation of QI medicine on the basis of the basic compatibility of the present invention, has increased the compatibility of Radix Scrophulariae, Bulbus Fritillariae Thunbergii formation hard masses softening and resolving, coordinates to work with blood circulation promoting and blood stasis dispelling such as rhizoma sparganic, Rhizoma Curcumae, Spina Gleditsiae, hard masses softening and resolving medicine.To cardinal symptom show as that breast is loose, more how long rope appears in one or both sides or lamellar agglomerate, lump size do not change with menstruation; The cyclomastopathy that pain does not show has significant curative effect.The spirit of III type health breast also can be as the ancillary drug of Breast Cancer Prevention and breast carcinoma rehabilitation.
According to the 'Kangruling ' medicine mixture of above embodiment preparation, owing to realized typing dispenser to the ill, good effect not only, the cure rate height, and greatly facilitate the treatment of the world of medicine to cyclomastopathy, have a extensive future.Moreover, the present invention is according to the typing of state of an illness symptom, the way of classification, also for the science that improves the treatment by Chinese herbs cyclomastopathy, policy-making, realizes that the computer management of Chinese traditional treatment lays the foundation.
Claims (2)
1, a kind of Chinese patent medicine for the treatment of cyclomastopathy---'Kangruling ' medicine mixture, this medicine is to start with from the endocrine regulation function, by tonify Qi of the kidney, the plurality of Chinese of regulating thoroughfare and controlling vessel, dispersing the stagnated live-QI to relieve the stagnation of QI, hard masses softening and resolving makes as its basic compatibility, it is characterized in that the spirit of health breast is according to the different state of an illness and symptom, typing has been prepared the 'Kangruling ' medicine mixture of different compatibilities on the basis of basic compatibility, I type, II type, three kinds of models of III type are arranged, refine into drink form with modern crafts processing behind the compatibility
The spirit of A, I type health breast is the pain type, be on the basis of the basic compatibility of the present invention, help with the Radix Curcumae of dispersing the stagnated live-QI to relieve the stagnation of QI, the Radix Paeoniae Alba etc. be mixed with Rhizoma Cyperi, Radix Bupleuri compatibility and, its concrete compatibility is:
Herba Epimedii 10～20g, Cornu Cervi Degelatinatum 10～15g, Rhizoma Cyperi 10～15g, Radix Bupleuri 10～15g, Thallus Laminariae (Thallus Eckloniae) 10～20g, Sargassum 10～20g, Radix Rhapontici 10～15g, Semen Vaccariae 10～20g, Squama Manis 10～15g, Concha Ostreae 30g, Medulla Tetrapanacis 5～10g, Rhizoma Chuanxiong 10～15g, Radix Curcumae 10～15g, the Radix Paeoniae Alba 10～15g
The spirit of B, II type health breast adds the lump type for pain, be on the basis of the basic compatibility of the present invention further assistant form with compatibility of drugss such as the Radix Paeoniae Rubra of blood circulation promoting and blood stasis dispelling, hard masses softening and resolving, rhizoma sparganic, Rhizoma Curcumae, Spina Gleditsiae, its concrete compatibility is:
Herba Epimedii 10～20g, Cornu Cervi Degelatinatum 10～20g, Rhizoma Cyperi 10～15g, Radix Bupleuri 10～15g, Thallus Laminariae (Thallus Eckloniae) 10～20g, Sargassum 10～20g, Semen Vaccariae 10～20g, Concha Ostreae 30g, Medulla Tetrapanacis 5～10g, Radix Paeoniae Rubra 10～15g, Squama Manis 10～15g, rhizoma sparganic 10～15g, Rhizoma Curcumae 10～15g, Spina Gleditsiae 10～15g
C, the spirit of III type health breast are the lump type, are the medicines that has increased Radix Scrophulariae, Bulbus Fritillariae Thunbergii hard masses softening and resolving on the basis of the basic compatibility of the present invention, and with rhizoma sparganic, Rhizoma Curcumae, Spina Gleditsiae coordinative role, its concrete compatibility is:
Radix Scrophulariae 10～20g, Herba Epimedii 10～20g, Cornu Cervi Degelatinatum 10～15g, Thallus Laminariae (Thallus Eckloniae) 10～20g, Sargassum 10～20g, Semen Vaccariae 10～20g, Concha Ostreae 30g, Medulla Tetrapanacis 5～10g, Squama Manis 10～15g, rhizoma sparganic 10～20g, Rhizoma Curcumae 10～20g, Spina Gleditsiae 10～20g, Bulbus Fritillariae Thunbergii 10～15g.
2, 'Kangruling ' medicine mixture as claimed in claim 1 is characterized in that this 'Kangruling ' medicine mixture can be mixed with the Chinese patent medicine of various ways such as pill, tablet, capsule, decoction.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN98102359A CN1060085C (en) | 1998-06-08 | 1998-06-08 | 'Kangruling' medicine mixture |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN98102359A CN1060085C (en) | 1998-06-08 | 1998-06-08 | 'Kangruling' medicine mixture |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1198941A true CN1198941A (en) | 1998-11-18 |
| CN1060085C CN1060085C (en) | 2001-01-03 |
Family
ID=5217290
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN98102359A Expired - Fee Related CN1060085C (en) | 1998-06-08 | 1998-06-08 | 'Kangruling' medicine mixture |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1060085C (en) |
Cited By (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1075386C (en) * | 1999-09-03 | 2001-11-28 | 聂翠新 | Method for producing Anruneixiao medicinal liquid |
| CN1086131C (en) * | 1999-08-20 | 2002-06-12 | 张四岩 | A kind of pharmaceutical composition for treating mammary gland hyperplasia |
| CN100361669C (en) * | 2006-05-30 | 2008-01-16 | 王怀民 | A Chinese medicinal preparation for treating mammary glands hyperplasia |
| CN100389815C (en) * | 2006-05-26 | 2008-05-28 | 雷秋模 | Medicine for treating mammary glands hyperplasia |
| CN101732528A (en) * | 2010-02-10 | 2010-06-16 | 李蕴 | Chinese medicament for treating of hyperplasia of mammary gland |
| CN101224290B (en) * | 2007-12-28 | 2010-07-14 | 李显成 | Chinese traditional medicine for treating breast nodules and preparing method thereof |
| CN102205071A (en) * | 2011-05-28 | 2011-10-05 | 吴汉利 | Chinese medicinal composition for treating thyroid cyst |
| CN103656532A (en) * | 2013-12-27 | 2014-03-26 | 丁丽 | Traditional Chinese medicine formula for treating breast hyperplasia |
| CN104435645A (en) * | 2014-12-17 | 2015-03-25 | 张瑞荣 | Traditional Chinese medicinal composition applied after breast cancer operation and preparation method of traditional Chinese medicinal composition |
-
1998
- 1998-06-08 CN CN98102359A patent/CN1060085C/en not_active Expired - Fee Related
Cited By (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1086131C (en) * | 1999-08-20 | 2002-06-12 | 张四岩 | A kind of pharmaceutical composition for treating mammary gland hyperplasia |
| CN1075386C (en) * | 1999-09-03 | 2001-11-28 | 聂翠新 | Method for producing Anruneixiao medicinal liquid |
| CN100389815C (en) * | 2006-05-26 | 2008-05-28 | 雷秋模 | Medicine for treating mammary glands hyperplasia |
| CN100361669C (en) * | 2006-05-30 | 2008-01-16 | 王怀民 | A Chinese medicinal preparation for treating mammary glands hyperplasia |
| CN101224290B (en) * | 2007-12-28 | 2010-07-14 | 李显成 | Chinese traditional medicine for treating breast nodules and preparing method thereof |
| CN101732528A (en) * | 2010-02-10 | 2010-06-16 | 李蕴 | Chinese medicament for treating of hyperplasia of mammary gland |
| CN102205071A (en) * | 2011-05-28 | 2011-10-05 | 吴汉利 | Chinese medicinal composition for treating thyroid cyst |
| CN103656532A (en) * | 2013-12-27 | 2014-03-26 | 丁丽 | Traditional Chinese medicine formula for treating breast hyperplasia |
| CN104435645A (en) * | 2014-12-17 | 2015-03-25 | 张瑞荣 | Traditional Chinese medicinal composition applied after breast cancer operation and preparation method of traditional Chinese medicinal composition |
Also Published As
| Publication number | Publication date |
|---|---|
| CN1060085C (en) | 2001-01-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102631513B (en) | Medicinal plaster for removing stasis, eliminating stagnation and relieving swelling and preparation method thereof | |
| CN104826016B (en) | A kind of pharmaceutical composition and its preparation method and application for treating the proliferation of mammary gland | |
| CN1060085C (en) | 'Kangruling' medicine mixture | |
| CN101502609B (en) | Chinese medicament preparation for cooling blood and dissolving stasis | |
| CN101647924A (en) | Traditional Chinese medicine formula for treating chronic pelvic inflammation in oral-taking way | |
| CN101095933A (en) | Chinese traditional medicine compound recipe for healing bones and treating wound | |
| CN103157055B (en) | Traditional Chinese medicine preparation for treating hyperplasia of mammary glands | |
| CN101810744A (en) | Formula of orally-taken Chinese medicament for treating hyperplasia of mammary glands | |
| CN103800840A (en) | Oral traditional Chinese medicine solution for treating cervical spondylosis | |
| CN100531787C (en) | A kind of traditional Chinese medicine preparation for treating uterine fibroids and preparation method thereof | |
| CN1186083C (en) | Chinese medicine for treating mammary gland foliole proliferation | |
| CN101961455A (en) | Traditional Chinese medicine for treating chronic colitis disease | |
| CN101461851A (en) | Chinese herbal medicine for treating hyperosteogeny | |
| CN111388543A (en) | Traditional Chinese medicine composition for treating gout and preparation and application thereof | |
| CN100352483C (en) | Externally applied medicine for treating mammary glands hyperplasia and preventing mammary cancer | |
| CN100427134C (en) | A Chinese traditional medicinal composition for treatment of cholecystitis | |
| CN114377092B (en) | Traditional Chinese medicine composition for treating wind-cold collateral-blocking nerve root type cervical spondylosis, preparation and application | |
| CN1261146C (en) | Plaster for treating hyperplasia of mammary glands | |
| CN101757355A (en) | Traditional Chinese medicine preparation for treating infertility | |
| CN106344818A (en) | Method for preparing traditional Chinese medicine composition for treating migraine | |
| CN104825720A (en) | Traditional Chinese medicine composition for treating dysmenorrhoea | |
| CN100350956C (en) | Medicine for treating hysteromyoma | |
| CN106511711A (en) | Traditional Chinese medicine formula for treating breast cancer | |
| CN118717879A (en) | A Chinese medicine composition for assisting osteoporosis rehabilitation | |
| CN103301399A (en) | Traditional Chinese medicine for treating pelvic inflammation |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| REG | Reference to a national code |
Ref country code: HK Ref legal event code: GR Ref document number: 1048338 Country of ref document: HK |
|
| C19 | Lapse of patent right due to non-payment of the annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |